Table of Content



Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased Database
1.3.1.2 Gvr’s Internal Database
1.3.2 Primary Research
1.4 Research Scope And Assumptions
1.5 List To Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 U.S. Minor Cannabinoids Market Variables, Trends & Scope
3.1 Penetration And Growth Prospect Mapping
3.2 Cannabis and Cannabinoids Regulatory Framework in U.S.
3.3 U.S. Cannabinoids Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 U.S. Minor Cannabinoids Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining Power Of The Suppliers
3.4.1.2 Bargaining Power Of The Buyers
3.4.1.3 Threats Of Substitution
3.4.1.4 Threats From New Entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTLE Analysis
3.4.2.1 Political Landscape
3.4.2.2 Economic Landscape
3.4.2.3 Social Landscape
3.4.2.4 Technological Landscape
3.4.2.5 Environmental Landscape
3.4.2.6 Legal Landscape
3.5 Major Deals & Strategic Alliances Analysis
3.6 Opportunity Analysis (2014-2020-2028)
3.7 Impact of COVID-19 on U.S. Minor Cannabinoids Market
Chapter 4 U.S. Minor Cannabinoids Market: Competitive Landscape Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
4.3 Company Market Position Analysis
Chapter 5 U.S. Minor Cannabinoids Market: Product Estimates & Trend Analysis
5.1 U.S. Minor Cannabinoids Market: Product Movement Analysis, USD Million, 2020 & 2028
5.2 Cannabigerol (CBG)
5.2.1 Cannabigerol (CBG) Market Estimates And Forecasts, 2014 - 2028 (USD Million)
5.3 Cannabichromene (CBC)
5.3.1 Cannabichromene (CBC) Market Estimates And Forecasts, 2014 - 2028 (USD Million)
5.4 Cannabinol (CBN)
5.4.1 Cannabinol (CBN) Market Estimates And Forecasts, 2014 - 2028 (USD Million)
5.5 Tetrahydrocannabivarin (THCV)
5.5.1 Tetrahydrocannabivarin (THCV) Market Estimates And Forecasts, 2014 - 2028 (USD Million)
5.6 Cannabigerolic acid (CBGA)
5.6.1 Cannabigerolic acid (CBGA) Market Estimates And Forecasts, 2014 - 2028 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2014 - 2028 (USD Million)
Chapter 6 U.S. Minor Cannabinoids Market: Application Estimates & Trend Analysis
6.1 U.S. Minor Cannabinoids Market: Application Movement Analysis, USD Million, 2020 & 2028
6.2 Inflammation
6.2.1 Inflammation Market Estimates And Forecasts, 2014 - 2028 (USD Million)
6.3 Pain Management
6.3.1 Pain Management Market Estimates And Forecasts, 2014 - 2028 (USD Million)
6.4 Neurological Disorders
6.4.1 Neurological Disorders Market Estimates And Forecasts, 2014 - 2028 (USD Million)
6.5 Cancer
6.5.1 Cancer Market Estimates And Forecasts, 2014 - 2028 (USD Million)
6.6 Others
6.6.1 Others Market Estimates And Forecasts, 2014 - 2028 (USD Million)
Chapter 7 Company Profiles
7.1 Mile High Labs International
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Global Cannabinoids
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 GenCanna
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 CBD INC
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Precision Plant Molecules
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Rhizo Sciences
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 LaurelCrest
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Fresh Bros Hemp Company
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 BulKanna
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 High Purity Natural Products
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 Zero Point Extraction
7.11.1 Company overview
7.11.2 Financial performance
7.11.3 Product benchmarking
7.11.4 Strategic initiatives
7.12 List of Other Companies



List of Figures

List of Figures

Fig. 1 U.S. minor cannabinoids market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. minor cannabinoids market snapshot, 2020 (USD Million)
Fig. 10 Penetration & growth prospects mapping
Fig. 11 U.S. minor cannabinoids market dynamics
Fig. 12 U.S. minor cannabinoids market driver impact
Fig. 13 U.S. minor cannabinoids market restraints impact
Fig. 14 U.S. minor cannabinoids market - PESTLE analysis
Fig. 15 U.S. minor cannabinoids market - Porter’s Analysis
Fig. 16 Opportunity analysis (2014-2020-2028)
Fig. 17 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 18 Company Market Position Analysis
Fig. 19 U.S. minor cannabinoids market, Product outlook: Key takeaways
Fig. 20 U.S. minor cannabinoids market: Product movement analysis (2020 & 2028) (USD Million)
Fig. 21 Cannabigerol (CBG) market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 22 Cannabichromene (CBC) market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 23 Cannabinol (CBN) market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 24 Tetrahydrocannabivarin (THCV) market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 25 Cannabigerolic acid (CBGA) market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 26 Other minor cannabinoids market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 27 U.S. minor cannabinoids market, Application outlook: Key takeaways
Fig. 28 U.S. minor cannabinoids market: Application movement analysis (2020 & 2028) (USD Million)
Fig. 29 Inflammation market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 30 Pain management market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 31 Neurological disorders market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 32 Cancer market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 33 Others market estimates and forecasts, 2014 - 2028 (USD Million)

List of Tables

List of Tables

Table 1 Partial list of secondary sources